Results 151 to 160 of about 15,266 (342)

Lessons from the implementation of the Australian 2016 prostate specific antigen testing clinical practice guidelines: a descriptive study

open access: yesANZ Journal of Surgery, EarlyView.
Abstract Introduction In 2025, prostate cancer is the most common cancer in Australia, regardless of gender, and is the second most common cause of cancer death despite the opportunities for cure. In 2016, Australian Clinical Practice Guidelines for Prostate Specific Antigen (PSA) testing were published to improve early detection and management of ...
Nicole Heneka   +5 more
wiley   +1 more source

Biological aggressiveness evaluation in prostate carcinomas: Immunohistochemical analysis of PCNA and p53 in a series of Gleason 6 (3+3) adenocarcinomas [PDF]

open access: yes, 2003
We selected 63 prostate tumors with Gleason's grade 6 (3+3), commonly showing both tubular and cribrous patterns. We compared in both patterns the expression of two of the most used biologic markers: PCNA and p53, with the aim to verify the validity of ...
ARAGONA, Federico   +8 more
core  

Analysis of influencing factors of acute kidney injury after unilateral nephrectomy

open access: yesScientific Reports
Unilateral Nephrectomy is one of the most common treatments for surgical diseases of the kidney but often results in postsurgical acute kidney injury (AKI).
Yongchao Yan   +5 more
doaj   +1 more source

BCG Intolerance in Nonmuscle Invasive Bladder Cancer—A Systematic Review

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Most patients with localized bladder cancer are initially managed with endoscopic resection. For high‐grade nonmuscle invasive bladder cancer (NMIBC), intravesical Bacillus Calmette‐Guerin (BCG) therapy is the gold standard adjuvant treatment.
Claris Oh   +4 more
wiley   +1 more source

A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy

open access: yesBJU International, Volume 135, Issue 4, Page 648-656, April 2025.
Objective To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non‐coding RNA (lncRNA)‐based genomic profiling has suggested utility in identifying a distinct tumour subgroup corresponding to a favourable prognosis in patients with bladder cancer.
Joep J. de Jong   +14 more
wiley   +1 more source

Association of bi‐parametric MRI measures with continence after robot‐assisted radical prostatectomy

open access: yesBJU International, Volume 135, Issue 4, Page 603-610, April 2025.
Objective To investigate the association between pre‐ and postoperative magnetic resonance imaging (MRI) measurements of the membranous urethra and the prostate volume and continence following robot‐assisted radical prostatectomy (RARP). Patients and Methods From December 2018 to June 2022, 100 continent patients undergoing unilateral nerve‐sparing or ...
Alexander B. Nolsøe   +8 more
wiley   +1 more source

3D‐printed model for resection of positive surgical margins in robot‐assisted prostatectomy

open access: yesBJU International, Volume 135, Issue 4, Page 657-667, April 2025.
Objectives To improve precision of secondary resection (SR) after positive surgical margin (PSM) detection by frozen section (FS) during nerve‐sparing (NS) robot‐assisted radical prostatectomy (RARP) by employing a personalised three‐dimensional (3D)‐printed prostate model derived from pelvic magnetic resonance imaging (MRI).
Christian Engesser   +12 more
wiley   +1 more source

Long‐term quality of life in patients with bladder cancer following radical cystectomy

open access: yesBJU International, Volume 135, Issue 4, Page 675-683, April 2025.
Objectives To investigate changes in quality of life (QoL) up to 8 years after radical cystectomy (RC) and compare QoL after RC with a gender‐ and age‐matched Dutch normative population. Furthermore, we aimed to identify patient characteristics associated with QoL and QoL trajectories after RC.
Emine Akdemir   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy